0001213900-22-024301.txt : 20220506
0001213900-22-024301.hdr.sgml : 20220506
20220505174528
ACCESSION NUMBER: 0001213900-22-024301
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220406
FILED AS OF DATE: 20220505
DATE AS OF CHANGE: 20220505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phillips Andrew John
CENTRAL INDEX KEY: 0001921956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39630
FILM NUMBER: 22897991
MAIL ADDRESS:
STREET 1: C/O CORMORANT ASSET MANAGEMENT, LLP
STREET 2: 200 CLARENDON STREET, FL 52
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MoonLake Immunotherapeutics
CENTRAL INDEX KEY: 0001821586
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
BUSINESS PHONE: 41 41 510 8022
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
FORMER COMPANY:
FORMER CONFORMED NAME: Helix Acquisition Corp
DATE OF NAME CHANGE: 20200818
4
1
ownership.xml
X0306
4
2022-04-06
0
0001821586
MoonLake Immunotherapeutics
MLTX
0001921956
Phillips Andrew John
C/O MOONLAKE IMMUNOTHERAPEUTICS
DORFSTRASSE 29
ZUG
V8
6300
SWITZERLAND
1
0
0
0
Option to Buy
12.25
2022-04-06
4
A
0
45000
0
A
2032-04-06
Class A ordinary shares, par value $0.0001 per share
45000
45000
D
Dr. Phillips was granted 45,000 options on April 6, 2022 pursuant to the MoonLake Immunotherapeutics 2022 Equity Incentive Plan (the "Plan"), vesting one-third on each of April 6, 2023, April 6, 2024 and April 6, 2025, in each case, subject to the terms of the Plan. Each option represents the right to acquire one Class A ordinary share, par value $0.0001 per share, of the Issuer.
/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew Phillips
2022-05-05